[1]
M. Lupina and J. Listos, “New perspectives on the use of glucagon-like peptide 1 in diseases of the central nervous system”, Curr. Issues Pharm. Med. Sci., vol. 36, no. 4, pp. 232–235, Dec. 2023, doi: 10.2478/cipms-2023-0040.